Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. Therapeutic alternatives: atorvastatin, fluvastatin, lovastatin, pravastatin. |
| PAHO Strategic Fund Medicine List | 6.6. Lipid-lowering agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. Therapeutic alternatives: atorvastatin, fluvastatin, lovastatin, pravastatin. |
| PAHO Strategic Fund Medicine List | 6.6. Lipid-lowering agents | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. Therapeutic alternatives: atorvastatin, fluvastatin, lovastatin, pravastatin. |
| PAHO Strategic Fund Medicine List | 6.6. Lipid-lowering agents | No observations |
| Peru | 12.6 Hypolipidemiants | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 12.6. Lipid-lowering agents |
Others observations: For use in high-risk patients. Therapeutic alternatives: atorvastatin, fluvastatin, lovastatin, pravastatin. |
| PAHO Strategic Fund Medicine List | 6.6. Lipid-lowering agents | No observations |
| Peru | 12.6 Hypolipidemiants | No observations |